{
    "2020-08-21": [
        [
            {
                "time": "",
                "original_text": "[路演]长春高新：目前公司鼻喷疫苗已获得10余个省份准入",
                "features": {
                    "keywords": [
                        "长春高新",
                        "鼻喷疫苗",
                        "准入",
                        "省份"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "长春高新(000661)：业绩保持快速增长 疫苗板块表现优异",
                "features": {
                    "keywords": [
                        "长春高新",
                        "业绩增长",
                        "疫苗",
                        "表现优异"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物板块回落-10%，哪些医药基金更抗跌？",
                "features": {
                    "keywords": [
                        "医药生物",
                        "板块回落",
                        "抗跌基金"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "长春高新上半年期间费用率降至41.2% 子公司金赛药业盈利11.3亿贡献九成净利润",
                "features": {
                    "keywords": [
                        "长春高新",
                        "费用率",
                        "金赛药业",
                        "盈利",
                        "净利润"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}